Todd Berard is Chief Marketing Officer of BIOLIFE SOLUTIONS INC. Currently has a direct ownership of 135,632 shares of BLFS, which is worth approximately $2.97 Million. The most recent transaction as insider was on Aug 10, 2022, when has been sold 52 shares (Common Stock) at a price of $23.17 per share, resulting in proceeds of $1,205. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 136K
26.68% 3M change
4.89% 12M change
Total Value Held $2.97 Million

Todd Berard Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 10 2022
SELL
Open market or private sale
$1,205 $23.17 p/Share
52 Reduced 0.05%
108,394 Common Stock
Jun 28 2022
SELL
Open market or private sale
$7,356 $14.86 p/Share
495 Reduced 0.45%
108,446 Common Stock
May 13 2022
SELL
Open market or private sale
$628 $12.32 p/Share
51 Reduced 0.05%
108,941 Common Stock
Apr 18 2022
SELL
Open market or private sale
$238,890 $17.59 p/Share
13,581 Reduced 11.08%
108,992 Common Stock
Apr 12 2022
BUY
Exercise of conversion of derivative security
-
32,136 Added 20.77%
122,573 Common Stock
Mar 29 2022
SELL
Open market or private sale
$10,564 $22.24 p/Share
475 Reduced 0.52%
90,437 Common Stock
Feb 24 2022
BUY
Grant, award, or other acquisition
-
14,019 Added 13.36%
90,912 Common Stock
Feb 10 2022
SELL
Open market or private sale
$7,463 $29.38 p/Share
254 Reduced 0.33%
76,893 Common Stock
Dec 29 2021
SELL
Open market or private sale
$20,354 $39.37 p/Share
517 Reduced 0.67%
77,147 Common Stock
Dec 07 2021
SELL
Open market or private sale
$365,200 $36.52 p/Share
10,000 Reduced 11.41%
77,664 Common Stock
Dec 07 2021
BUY
Exercise of conversion of derivative security
$26,200 $2.62 p/Share
10,000 Added 10.24%
87,664 Common Stock
Nov 16 2021
SELL
Open market or private sale
$311,881 $50.63 p/Share
6,160 Reduced 7.35%
77,664 Common Stock
Nov 16 2021
BUY
Exercise of conversion of derivative security
$10,102 $1.64 p/Share
6,160 Added 6.85%
83,824 Common Stock
Nov 15 2021
SELL
Open market or private sale
$295,434 $47.96 p/Share
6,160 Reduced 7.35%
77,664 Common Stock
Nov 15 2021
BUY
Exercise of conversion of derivative security
$10,102 $1.64 p/Share
6,160 Added 6.85%
83,824 Common Stock
Oct 15 2021
SELL
Open market or private sale
$251,082 $40.76 p/Share
6,160 Reduced 7.35%
77,664 Common Stock
Oct 15 2021
BUY
Exercise of conversion of derivative security
$10,102 $1.64 p/Share
6,160 Added 6.85%
83,824 Common Stock
Oct 14 2021
SELL
Open market or private sale
$281,565 $39.91 p/Share
7,055 Reduced 8.33%
77,664 Common Stock
Oct 14 2021
BUY
Exercise of conversion of derivative security
$10,102 $1.64 p/Share
6,160 Added 6.85%
83,824 Common Stock
Sep 28 2021
SELL
Open market or private sale
$21,776 $43.12 p/Share
505 Reduced 0.64%
78,559 Common Stock
Sep 16 2021
SELL
Open market or private sale
$283,976 $46.1 p/Share
6,160 Reduced 7.23%
79,064 Common Stock
Sep 16 2021
BUY
Exercise of conversion of derivative security
$10,102 $1.64 p/Share
6,160 Added 6.74%
85,224 Common Stock
Sep 15 2021
SELL
Open market or private sale
$301,902 $49.01 p/Share
6,160 Reduced 7.23%
79,064 Common Stock
Sep 15 2021
BUY
Exercise of conversion of derivative security
$10,102 $1.64 p/Share
6,160 Added 6.74%
85,224 Common Stock
Aug 17 2021
SELL
Open market or private sale
$275,968 $44.8 p/Share
6,160 Reduced 7.23%
79,064 Common Stock
TB

Todd Berard

Chief Marketing Officer
Bothell, WA

Track Institutional and Insider Activities on BLFS

Follow BIOLIFE SOLUTIONS INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BLFS shares.

Notify only if

Insider Trading

Get notified when an Biolife Solutions Inc insider buys or sells BLFS shares.

Notify only if

News

Receive news related to BIOLIFE SOLUTIONS INC

Track Activities on BLFS